Bactroban
Drug name: Bactroban
Active Ingredients:
- Mupirocin calcium
Indications: Bactroban is used to treat:
- impetigo caused by Staphylococcus aureus or Streptococcus pyogenes
- infected eczema
- folliculitis
Contraindications and cautions:
You should not use Bactroban ointment :
- if you have an to mupirocin
You should talk with your health care provider prior to taking Bactroban:
- if you have
- if you have kidney disease
- if you are going to treat a burn or open wound
- if you are pregnant
- if you breastfeeding
- if you have any to drugs, food, preservatives
Warning!
- Avoid contact with the eyes
- Bactroban is not for use on mucosal surfaces
- Bactroban is for external use only.
- Long use of Bactroban can cause another infection
- You should use Bactroban with caution in infants
- You should use Bactroban the whole course of treatment. Do not stop using this even if you feel better.
Adverse effects: There are possible side-effects associated with this medicine that can affect individuals in different ways. If a side effect is stated here, that does not necessarily mean the fact that all people using Bactroban will experience it or any other.
- burning
- headache
- stinging.
- Nausea.
- reactions such as rash, hives, itching, breathing disorders
- pain in the chest
- swelling of the mouth, face, lips, or tongue;
- severe irritation;
- severe itching.
The side effects listed above may not include all of the side effects reported by the drug's manufacturer.
For more information about any other possible risks associated with mupirocin, please read the information provided with Bactroban ointment or consult your doctor or pharmacist.
Interactions: It is important to tell your doctor or pharmacist what you are already taking, including those bought without a prescription and medicines, before you start treatment with mupirocin. Similarly, check with your doctor or pharmacist before taking any new medication while taking this one, to ensure that the combination is safe.
Additional Information: DO NOT SHARE Bactroban with others. DO NOT USE THIS MEDICINE for other health conditions. KEEP THIS PRODUCT, as well as syringes and needles, if needed during treatment, out of the reach of children. Do not reuse needles, syringes, or other materials.
Category News�3>
04/17/07 - GSK Announces FDA Approval Of Altabax™ (retapamulin Ointment), 1%
GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains o...
04/17/07 - GSK Announces FDA Approval Of Altabax(TM) (Retapamulin Ointment), 1%
GlaxoSmithKline (NYSE:
GSK) announced today that the U.S. Food and Drug Administration (FDA) has
approved its antibacterial Altabax for the topical treatment of impetigo
due to susceptible st...
03/29/07 - GlaxoSmithKline Announces Altargo® Receives Positive Opinion In Europe For Treatment Of Impetigo And Other Skin Infections
GlaxoSmithKline (GSK) today announced that its new, novel topical antibiotic ALTARGO® (retapamulin ointment, 1%) received a positive opinion from the European Committee for Human Medicinal Produ...
GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains o...
GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible st...
GlaxoSmithKline (GSK) today announced that its new, novel topical antibiotic ALTARGO® (retapamulin ointment, 1%) received a positive opinion from the European Committee for Human Medicinal Produ...
